This meeting has been organised by the Haemophilia Academy. Novo Nordisk and CSL Behring have provided a grant to the Haemophilia Academy to fund the costs associated with organising this educational meeting. Novo Nordisk and CSL Behring have had no influence into the content or arrangements for this meeting.
The Haemophilia Academy is led by a distinguished Faculty of haemophilia experts from around the world.
Claude Négrier was head of the Haematology Department at Hôpital Louis Pradel in Lyon, France and Director of the Haemophilia Comprehensive Care Centre at this institution until the end of last year. He is currently Emeritus Professor of Haematology at the university of Lyon.
Roseline d’Oiron is a Clinician Investigator and Associate Director at the Reference Centre for Haemophilia and Other Congenital Rare Bleeding Disorders, Congenital Platelets Disorders and von Willebrand Disease at Bicêtre Hospital AP-HP – University Paris XI, Le Kremlin–Bicêtre, France. She is also responsible for Specialist training for the master’s degree in haematology at University Paris VII.
Keith Hoots joined the National Heart, Lung and Blood Institute of the U.S. National Institutes of Health (NIH) as Director, Division of Blood Diseases and Resources in January, 2009. In this role he directs the NIH extramural grant research programme for haematological diseases, which funds researchers across the U.S. and around the world.
Stacy Croteau is a paediatric haematologist and clinical investigator at Boston Children’s Hospital and an Assistant Professor of Pediatrics at Harvard Medical School, where she specialises in bleeding and clotting disorders. Dr. Croteau is the Head of the Haemophilia/vWD programme at Boston Children’s Hospital and Medical Director for the Boston Hemophilia Center serving Boston Children’s Hospital and Brigham and Women’s Hospital.
Professor Margareth Ozelo is Director of the WFH International Haemophilia Training Centre (IHTC) at the University of Campinas (UNICAMP) in Campinas, São Paulo, Brazil. She received her medical degree (1994), specialist training in haematology and transfusion medicine (1994-1997), and PhD (2004) from Unicamp before undertaking a postdoctoral fellowship in David Lillicrap’s laboratory, at Queen’s University in Kingston, Ontario, Canada (2006–2009).
Dr Maria Elisa Mancuso is a haematologist and works as a Senior Hematology Consultant at the Center for Thrombosis and Hemorrhagic Diseases at the IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy. She is also Adjunct Clinical Professor at Humanitas University. Dr Mancuso has postgraduate degree in clinical and experimental haematology and a PhD in clinical methodology.
Victor Blanchette is Medical Director of the Paediatric Thrombosis and Haemostasis Programme in the Division of Haematology/Oncology at the Hospital for Sick Children, Toronto, and Medical Director of the SickKids-Caribbean Pediatric Cancer and Blood Disorders Initiative (SCI). He is also Professor of Pediatrics at the University of Toronto, Canada, where he is a Senior Associate Scientist in the Research Institute and a Clinician Investigator in the Department of Paediatrics.
Christopher Ludlam is Emeritus Professor of Haematology and Coagulation Medicine at the University of Edinburgh and former Director of the Haemophilia and Thrombosis Centre at the Royal Infirmary of Edinburgh.
Professor Lillicrap is a Professor in the Department of Pathology and Molecular Medicine at Queen’s University, Kingston, Canada. Since 2000, he has been the recipient of a Canada Research Chair in Molecular Hemostasis. In 2013, he was elected to the Fellowship of the Royal Society of Canada.
Johannes Oldenburg is Director of the Institute of Experimental Haematology and Transfusion Medicine and the Haemophilia Centre at the University Clinic in Bonn, Germany. He completed his specialty training in transfusion medicine at the University of Bonn and in medical genetics at the University of Wuerzburg.
Jørgen Ingerslev was formerly Professor in Haemostasis and Thrombosis at Aarhus University, Denmark, and a Haemophilia Centre Director at the National Haemophilia Center of Western Denmark. This centre provides services to younger patients with venous thromboembolism and occlusive cerebrovascular disease.
